Assay of 25-hydroxyvitamin D3 in human plasma by high-performance liquid chromatography. 1979

N Matsuyama, and T Okano, and K Takada, and T Takao, and Y Terao, and N Hashimoto, and T Kobayashi

A method using preparative and analytical high-performance liquid chromatography (HPLC) is proposed for the assay of 25-hydroxyvitamin D3 (25-OH-D3) in human plasma. A constant volume (0.2--2.0 ml) of a plasma sample was saponified. The unsaponifiable matter was first applied to preparative HPLC using a column of the straight-phase type (Zorbax SIL) in order to separate a 25-OH-D3 fraction from lipophilic concomitants giving ultraviolet-absorbing noise. Then, the separated 25-OH-D3 fraction was applied to analytical HPLC using a column of the reversed-phase type (Zorbax ODS) in order to measure the content of 25-OH-D3 from the peak height. This is a revised method from Jones (1978): Clin. Chem., 24, 287--298). The results showed that the clean-up procedure by the first preparative HPLC was successfully performed because the peak corresponding to 25-OH-D3 on the chromatogram of the second analytical HPLC was not disturbed by any other interfering peaks. Moreover, recovery through the whole procedure was satisfacotry (about 100%) and the procedures of saponification and isolation of the unsaponifiable matter diminished the overload to the columns. These are the revised points of Jones' method. When two determinations were performed on 12 samples of plasma taken from normal adults in October, the values were 22.6 +/- 4.8 and 21.0 +/- 3.6 (mean +/- SD) ng/ml, respectively.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002112 Calcifediol The major circulating metabolite of VITAMIN D3. It is produced in the LIVER and is the best indicator of the body's vitamin D stores. It is effective in the treatment of RICKETS and OSTEOMALACIA, both in azotemic and non-azotemic patients. Calcifediol also has mineralizing properties. 25-Hydroxycholecalciferol,25-Hydroxyvitamin D 3,25-Hydroxycholecalciferol Monohydrate,25-Hydroxyvitamin D3,Calcidiol,Calcifediol Anhydrous,Calcifediol, (3 alpha,5Z,7E)-Isomer,Calcifediol, (3 beta,5E,7E)-Isomer,Calderol,Dedrogyl,Hidroferol,25 Hydroxycholecalciferol,25 Hydroxycholecalciferol Monohydrate,25 Hydroxyvitamin D 3,25 Hydroxyvitamin D3,Anhydrous, Calcifediol,Monohydrate, 25-Hydroxycholecalciferol
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006887 Hydroxycholecalciferols Hydroxy analogs of vitamin D 3; (CHOLECALCIFEROL); including CALCIFEDIOL; CALCITRIOL; and 24,25-DIHYDROXYVITAMIN D 3. Hydroxyvitamins D,Hydroxycholecalciferol
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

N Matsuyama, and T Okano, and K Takada, and T Takao, and Y Terao, and N Hashimoto, and T Kobayashi
August 1981, Clinical chemistry,
N Matsuyama, and T Okano, and K Takada, and T Takao, and Y Terao, and N Hashimoto, and T Kobayashi
February 1995, Journal of chromatographic science,
N Matsuyama, and T Okano, and K Takada, and T Takao, and Y Terao, and N Hashimoto, and T Kobayashi
May 1977, Analytical biochemistry,
N Matsuyama, and T Okano, and K Takada, and T Takao, and Y Terao, and N Hashimoto, and T Kobayashi
January 1995, Biomedical chromatography : BMC,
N Matsuyama, and T Okano, and K Takada, and T Takao, and Y Terao, and N Hashimoto, and T Kobayashi
February 1997, Journal of chromatography. B, Biomedical sciences and applications,
N Matsuyama, and T Okano, and K Takada, and T Takao, and Y Terao, and N Hashimoto, and T Kobayashi
January 1986, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition,
N Matsuyama, and T Okano, and K Takada, and T Takao, and Y Terao, and N Hashimoto, and T Kobayashi
September 1977, Clinical chemistry,
N Matsuyama, and T Okano, and K Takada, and T Takao, and Y Terao, and N Hashimoto, and T Kobayashi
December 1991, The Analyst,
N Matsuyama, and T Okano, and K Takada, and T Takao, and Y Terao, and N Hashimoto, and T Kobayashi
January 1981, Journal of nutritional science and vitaminology,
N Matsuyama, and T Okano, and K Takada, and T Takao, and Y Terao, and N Hashimoto, and T Kobayashi
February 1978, Clinical chemistry,
Copied contents to your clipboard!